Human cytomegalovirus, a member of the Betaherpesviridae, has the ability to establish lifelong persistent and usually latent infection. Following primary infection (asymptomatic or symptomatic: CMV mononucleosis), cytomegalovirus disease is generally restricted to the immunocompromised or immunologically immature host. In transplant patients, infection with cytomegalovirus from thedonor organ or the reactivation of cytomegalovirus in the recipient can lead to disease development. Cytomegalovirus remains one of the most importantinfections in solid organ transplant recipients and is associated with significant morbidity and mortality. Prevention and therapy of cytomegalovirus infections in solid organ transplantation are presented.

Rights

URN

URN:NBN:SI:DOC-NCMKA5TQ

COBISSID

28295129

Added

30.01.2012

Metadata

Citation

APA:

Tomažič, Janez (2011). Preprečevanje in zdravljenje okužb, povzročenih z virusom citomegalije, pri presaditvah čvrstih organov. Zdravniški vestnik, volume 80, issue 4, str. 285-292. URN:NBN:SI:DOC-NCMKA5TQ from http://www.dlib.si

MLA:

Tomažič, Janez. "Preprečevanje in zdravljenje okužb, povzročenih z virusom citomegalije, pri presaditvah čvrstih organov." Zdravniški vestnik volume 80. issue 4 (2011) str. 285-292.
<http://www.dlib.si/?URN=URN:NBN:SI:DOC-NCMKA5TQ>

Zdravniški vestnik
1992-
(Assembly record)

Preprečevanje in zdravljenje okužb, povzročenih z virusom citomegalije, pri presaditvah čvrstih organovPrevention and treatment of cytomegalovirus infections in solid organ transplantation

Preprečevanje in zdravljenje okužb, povzročenih z virusom citomegalije, pri presaditvah čvrstih organov
Prevention and treatment of cytomegalovirus infections in solid organ transplantation